Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-09-12 Regulatory Filings
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical AB presenterar vid Aktiedagen den 26 september i Göteborg
Regulatory Filings Classification · 95% confidence The document is a short press release (1474 characters) dated September 12, 2016, announcing that Episurf Medical AB will be presenting at an event called 'Aktiedagen' (Shareholder Day) on September 26th in Gothenburg. It provides details about the event and the attending representative (CFO). Crucially, it is an announcement *about* an upcoming presentation/event, not the presentation material itself (IP) or the results of a vote (DVA) or a general regulatory filing (RNS). Since the document is an announcement regarding the company's participation in an investor-facing event, it most closely aligns with an Investor Presentation (IP) announcement, or potentially a general Regulatory Filing (RNS) if 'IP' is reserved for the actual presentation slides. However, given the context of 'Aktiedagen' which is an investor event, and the short nature of the text announcing participation, it functions as a notification about investor relations activity. Since there is no specific code for 'Announcement of Investor Event Participation', and it is not the actual presentation (IP), the most appropriate general category for a brief, non-financial, non-board-related regulatory announcement is Regulatory Filings (RNS). The final sentence mentions compliance with the EU Market Abuse Regulation, confirming its regulatory nature.
2016-09-12 Swedish
Episurf Medical AB to present at Aktiedagen, held in Gothenburg on September 26
Regulatory Filings Classification · 95% confidence The document is a short 'Company Announcement' dated September 12, 2016, stating that Episurf Medical AB will present at an investor conference ('Aktiedagen') on September 26. It provides details about the event and contact information. It is not a formal financial report (like 10-K or IR), nor is it a transcript (CT) or a formal regulatory filing detailing financial results (ER/IR). Since it is an announcement about a future event where the company will present information to investors, it most closely aligns with general investor relations communication. Given the options, it is a general announcement that doesn't fit the specific financial or corporate action codes. It is best classified as a general Regulatory Filing (RNS) as it is a mandatory public disclosure under EU Market Abuse Regulation, but its content is promotional/informational regarding an investor event, making RNS the most appropriate fallback.
2016-09-12 English
Kommuniké från extra bolagsstämma i Episurf Medical AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kommuniké från extra bolagsstämma i Episurf Medical AB (publ)" (Communication from the Extraordinary General Meeting in Episurf Medical AB (publ)). It details decisions made at this meeting, specifically concerning the election of new board members (including the chairman), the approval of board remuneration, and the introduction of a new employee stock option program involving a directed issue of warrants. These actions—board changes, remuneration, and capital structure changes related to employee incentives—are core components of corporate governance and shareholder meetings. Since the document explicitly reports the outcomes of a general meeting (Extraordinary General Meeting), the most fitting category is AGM-R (AGM Information), as it covers the results and decisions stemming from a shareholder meeting, even if it is an 'extra' one. While it touches upon capital structure (CAP) via the options program, the primary context is the meeting itself.
2016-08-18 Swedish
Summary from extraordinary general meeting of Episurf Medical AB (publ)
AGM Information Classification · 99% confidence The document is titled 'Summary from extraordinary general meeting of Episurf Medical AB (publ)' and details resolutions passed at an Extraordinary General Meeting (EGM) held on August 18, 2016. Key items include the election of new board members, setting director fees, and approving an employee stock option program involving warrants. Since the document summarizes the outcomes and resolutions of a shareholder meeting, it directly relates to the governance and voting process. While it is a summary, the content is about the results of a vote (board elections, option program approval). However, the definitions provided do not have a specific code for 'Extraordinary General Meeting Summary' or 'Shareholder Meeting Results' other than DVA (Declaration of Voting Results & Voting Rights Announcements). Given that the meeting occurred and the document summarizes the decisions made, DVA is the most appropriate fit, as the election of directors and approval of the option program are formal shareholder votes. It is not a standard AGM presentation (AGM-R) because it is an EGM summary, and it is not a DEF 14A (Remuneration) as it covers more than just pay. It is a direct report of meeting outcomes.
2016-08-18 English
Episurf Medical has been granted additional European patent
Regulatory Filings Classification · 90% confidence The document is a short 'Company Announcement' dated August 1, 2016, detailing that Episurf Medical has been granted an additional European patent for a surgical drilling guide. This announcement focuses on the generation and protection of intellectual property (IP). Reviewing the definitions, none of the specific codes (like 10-K, ER, DIV, etc.) directly match an announcement about a patent grant. The content is a specific update regarding proprietary technology and IP protection. Since it is not a standard financial report, management change, or transaction, it falls best under the general regulatory announcement category, which is 'Regulatory Filings' (RNS), as it is a mandatory disclosure under the EU Market Abuse Regulation, but doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP). The document length is short (1913 chars), but it is the primary content, not an announcement *of* another report, so the RPA rule does not strictly apply here.
2016-08-01 English
Episurf Medical beviljas ytterligare patent i Europa
Regulatory Filings Classification · 95% confidence The document is a press release dated August 1, 2016, announcing that Episurf Medical has been granted a new patent in Europe for a surgical drill guide. It discusses the importance of patent protection and mentions the company's current patent portfolio. This type of announcement, concerning intellectual property rights and innovation protection, does not fit neatly into the primary financial reporting categories (10-K, IR, ER, etc.). It is a specific corporate update related to assets/technology. Since there is no specific code for 'Patent Grant Announcement', and it is a formal announcement of a corporate event/development, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for official regulatory announcements that don't fit elsewhere, especially given the concluding statement referencing the EU Market Abuse Regulation (MAR). The document length is short (1862 chars), but it is the primary content, not an announcement *of* another report.
2016-08-01 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.